Medartis Holding AG
MDRSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.41 | -3.36 | 1.71 | -0.55 |
| FCF Yield | 0.41% | 2.06% | 0.41% | 1.49% |
| EV / EBITDA | 32.14 | 54.66 | 65.20 | 50.13 |
| Quality | ||||
| ROIC | -5.36% | 99.33% | -0.77% | 2.56% |
| Gross Margin | 79.52% | 78.66% | 80.30% | 80.76% |
| Cash Conversion Ratio | -5.96 | 23.63 | 3.63 | 15.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.05% | 19.68% | 19.10% | 16.23% |
| Free Cash Flow Growth | -84.26% | 302.64% | -68.04% | 209.69% |
| Safety | ||||
| Net Debt / EBITDA | 0.17 | -1.26 | -0.39 | 0.95 |
| Interest Coverage | 0.00 | 3.95 | -1.85 | 1.80 |
| Efficiency | ||||
| Inventory Turnover | 0.29 | 0.31 | 0.28 | 0.31 |
| Cash Conversion Cycle | 317.79 | 298.33 | 329.13 | 296.75 |